1
|
Dedopoulou P, Rodis N, Lampropoulos C, Kitsou KS, Mpogiatzopoulos N, Kehagias I. Synchronous Primary Gallbladder and Colon Adenocarcinoma: A Case Report and Systematic Literature Review. Cureus 2024; 16:e69092. [PMID: 39391434 PMCID: PMC11466057 DOI: 10.7759/cureus.69092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/10/2024] [Indexed: 10/12/2024] Open
Abstract
Synchronous primary malignancies, defined as two or more primary malignancies diagnosed simultaneously or within six months, are uncommon and present unique diagnostic and therapeutic challenges. Synchronous primary adenocarcinoma of the gallbladder and colon is particularly rare. We report a case of a 48-year-old female presenting with persistent right upper abdominal pain. Laboratory tests and imaging studies initially suggested xanthogranulomatous cholecystitis. However, subsequent laparoscopic cholecystectomy and pathological examination revealed a moderately differentiated adenocarcinoma of the gallbladder (pT2bN1M0). Further staging with CT and PET-CT scans identified a suspicious mass in the transverse colon, confirmed by colonoscopy and surgical resection as well-differentiated adenocarcinoma of the transverse colon (pT3N0M0). Immunohistochemistry and genetic profiling of both tumors indicated distinct primary origins without loss of mismatch repair (MMR) protein expression. The patient underwent additional liver resection, lymph node dissection, and right extended hemicolectomy. She is currently undergoing further staging and awaiting chemotherapy. A review of English-language literature revealed eight reported cases of synchronous primary gallbladder and colorectal cancer and a total of 13 with synchronous primary malignancy of other organs. Such cases are rare and diagnostically complex cases. Common factors contributing to multiple primary malignancies (MPM) include genetic predispositions, previous cancer treatments, and lifestyle factors such as smoking and alcohol consumption. This case underscores the importance of thorough investigation and prompt treatment in patients suspected of having MPM. Advances in diagnostic imaging and molecular profiling are crucial for early detection and tailored therapeutic strategies. Standardized guidelines for managing synchronous cancers are needed to improve patient outcomes.
Collapse
Affiliation(s)
| | - Nikiforos Rodis
- Department of Surgery, General University Hospital of Patras, Patras, GRC
| | | | | | | | - Ioannis Kehagias
- Department of Surgery, General University Hospital of Patras, Patras, GRC
| |
Collapse
|
2
|
Doulberis M, Rüedi C, Schmidt J, Kulaksiz H. WHERE GASTROENTEROLOGY AND UROLOGY MEET; AN UNEXPECTED CAUSE OF MACROHEMATURIA DIAGNOSED BY GASTROINTESTINAL ENDOSCOPY. Gastroenterol Nurs 2023; 46:497-500. [PMID: 37126078 DOI: 10.1097/sga.0000000000000731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2022] [Accepted: 01/17/2023] [Indexed: 05/02/2023] Open
Affiliation(s)
- Michael Doulberis
- Michael Doulberis, MD, DVM, PhD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland; Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland; Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece
- Christian Rüedi, MD, is in Urological private practice, Zurich, Switzerland
- Jan Schmidt, MD, MME, is at Surgery Section, Hirslanden Klinik im Park, Zurich, Switzerland
- Hasan Kulaksiz, MD, is at Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Hasan Kulaksiz, MD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland
| | - Christian Rüedi
- Michael Doulberis, MD, DVM, PhD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland; Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland; Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece
- Christian Rüedi, MD, is in Urological private practice, Zurich, Switzerland
- Jan Schmidt, MD, MME, is at Surgery Section, Hirslanden Klinik im Park, Zurich, Switzerland
- Hasan Kulaksiz, MD, is at Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Hasan Kulaksiz, MD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland
| | - Jan Schmidt
- Michael Doulberis, MD, DVM, PhD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland; Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland; Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece
- Christian Rüedi, MD, is in Urological private practice, Zurich, Switzerland
- Jan Schmidt, MD, MME, is at Surgery Section, Hirslanden Klinik im Park, Zurich, Switzerland
- Hasan Kulaksiz, MD, is at Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Hasan Kulaksiz, MD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland
| | - Hasan Kulaksiz
- Michael Doulberis, MD, DVM, PhD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland; Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland; Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece
- Christian Rüedi, MD, is in Urological private practice, Zurich, Switzerland
- Jan Schmidt, MD, MME, is at Surgery Section, Hirslanden Klinik im Park, Zurich, Switzerland
- Hasan Kulaksiz, MD, is at Faculty of Medicine, University of Freiburg, Freiburg, Germany
- Hasan Kulaksiz, MD, is at Gastroenterology Section, Hirslanden Klinik im Park, Zurich, Switzerland
| |
Collapse
|
3
|
Robertson D, Ng SK, Baade PD, Lam AK. Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2022; 37:541-551. [PMID: 35152308 PMCID: PMC8885556 DOI: 10.1007/s00384-022-04105-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/02/2022] [Indexed: 02/04/2023]
Abstract
PURPOSE The purpose of the study is to assess the global risk of extracolonic secondary primary cancers (SPCs) in patients with colorectal cancer (CRC). METHODS Studies of SPC in patients with CRC were included if they reported the standardised incidence ratio (SIR) for extracolonic SPCs in patients with CRC compared with the general population. Pooled summary estimates were calculated using a random-effects model. RESULTS A total of 7,716,750 patients with CRC from 13 retrospective cohort studies that reported extracolonic SPC incidence were included. The overall risk of several SPCs was significantly higher in patients with CRC compared with the general population, including cancers of the urinary bladder (pooled SIR 1.19, 95% confidence interval (CI) 1.06-1.33; p = 0.003), female genital tract (1.88, 1.07-3.31; p = 0.03), kidney (1.50, 1.19-1.89; p = 0.0007), thorax (lung, bronchus and mediastinum) (1.16, 1.01-1.32; p = 0.03), small intestine (4.26, 2.58-7.01; p < 0.0001), stomach (1.22, 1.07-1.39; p = 0.003), and thyroid (1.40, 1.28-1.53; p < 0.0001), as well as melanoma (1.28, 1.01-1.62; p = 0.04). There was also a decreased risk of developing cancer of the gall bladder (0.75, 0.60-0.94; p = 0.01). CONCLUSION Patients with CRC had a significantly increased risk of extracolonic SPCs compared with the general population. These findings highlight the need to develop research strategies for the management of second primary cancer in patients with CRC.
Collapse
Affiliation(s)
- Dylan Robertson
- School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia
| | - Shu Kay Ng
- School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia
| | - Peter D Baade
- School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia
- Cancer Council Queensland, Brisbane, QLD, Australia
| | - Alfred K Lam
- School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
- Pathology Queensland, Gold Coast University Hospital, Gold Coast, QLD, Australia.
- Pathology, School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Southport, QLD, 4222, Australia.
| |
Collapse
|